Gilla Kaplan

发表

A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death.

G. Kaplan, L. Tsenova, K. Sokol, 1998, The Journal of infectious diseases.

Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.

P. Haslett, G. Kaplan, J. Musser, 1999, Journal of immunology.

Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2

R. Steinman, G. Kaplan, P. Kushner, 1983, The Journal of experimental medicine.

Recent advances in cytokine therapy in leprosy.

G. Kaplan, Gilla Kaplan, 1993, The Journal of infectious diseases.

Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin

G. Kaplan, P. Laochumroonvorapong, A. Molloy, 1994, The Journal of experimental medicine.

The cutaneous infiltrates of leprosy. A transmission electron microscopy study

Gilla Kaplan, Nadia Nogueira, Z. A. Cohn, 1983, The Journal of experimental medicine.

The selective binding and transmigration of monocytes through the junctional complexes of human endothelium

G. Kaplan, N. Pawlowski, Z. Cohn, 1988, The Journal of experimental medicine.

Keratinocyte growth regulation by the products of immune cells

G. Kaplan, Z. Cohn, G. Hancock, 1988, The Journal of experimental medicine.

Nonadherent cultures of human monocytes kill Mycobacterium smegmatis, but adherent cultures do not

G. Kaplan, H. Fan, Z. Cohn, 1996, Infection and immunity.

Distribution and turnover of Langerhans cells during delayed immune responses in human skin

G. Kaplan, Z. Cohn, M. Witmer, 1987, The Journal of experimental medicine.

Widespread intradermal accumulation of mononuclear leukocytes in lepromatous leprosy patients treated systemically with recombinant interferon gamma

K. Squires, C. Nathan, C. K. Job, 1990, The Journal of experimental medicine.

Influence of delayed immune reactions on human epidermal keratinocytes.

R. Steinman, G. Kaplan, E. Sarno, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.

G. Kaplan, C. Nathan, E. Sarno, 1987, The American journal of pathology.

Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route

G. Kaplan, A. Moreira, J. Wang, 1997, Infection and immunity.

The generation of antigen-specific, major histocompatibility complex- restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2

G. Kaplan, Z. Cohn, G. Hancock, 1989, The Journal of experimental medicine.

Thalidomide protects mice against LPS-induced shock.

G. Kaplan, A. Moreira, J. Wang, 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes

K. Smith, G. Kaplan, P. Meyn, 1993, Journal of Experimental Medicine.

Immune stimulation in scleroderma patients treated with thalidomide.

G. Kaplan, A. Moreira, S. Oliver, 2000, Clinical immunology.

Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals

G. Kaplan, E. Sampaio, E. Sarno, 1995, Infection and immunity.

Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals

G. Kaplan, A. Moreira, E. Sampaio, 1995, Infection and Immunity.

Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals.

G. Kaplan, M. McElrath, Z. Cohn, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae.

G. Kaplan, C. K. Job, Z. Cohn, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro.

G. Kaplan, A. Moreira, W. Ye, 1997, AIDS research and human retroviruses.

The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients

G. Kaplan, Z. Cohn, I. Nath, 1988, The Journal of experimental medicine.

Hansen's disease, cell-mediated immunity, and recombinant lymphokines.

G. Kaplan, Z. Cohn, Gilla Kaplan, 1991, The Journal of infectious diseases.

The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2

G. Kaplan, T. Ottenhoff, P. Converse, 1989, The Journal of experimental medicine.

Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection

G. Kaplan, H. Teppler, K. Smith, 1993, The Journal of experimental medicine.

Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization

Gilla Kaplan, Barry R. Bloom, Robert L. Modlin, 1989, The Journal of experimental medicine.

How Mycobacterium leprae infects peripheral nerves.

G. Kaplan, D. E. Weinstein, V. Freedman, 1999, Leprosy Review.

Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions.

Gilla Kaplan, 2000, Leprosy review.

Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions.

G. Kaplan, Gilla Kaplan, 2000, Leprosy Review.

Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice

G. Kaplan, M. McElrath, Z. Cohn, 1987, The Journal of experimental medicine.

Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice

G. Kaplan, A. Moreira, W. Ye, 1997, Infection and immunity.

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.

D. Nixon, S. M. Donahoe, P. Haslett, 2000, The Journal of infectious diseases.

Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity.

G. Kaplan, L. Corral, G Kaplan, 1996, Journal of medicinal chemistry.